Before interpreting lipid-related findings, we note that key covariates were unavailable in this retrospective dataset, including adiposity and metabolic status (e.g., BMI, HOMA-IR), liver injury and disease activity markers (ALT/AST and fibrosis stage), HBV phase markers (e.g., HBeAg), and medication use (e.g., statins, thyroid agents), as well as major comorbidities (e.g., diabetes, metabolic syndrome). The gene discussed is GPT; the disease is metabolic syndrome.